SH3BGR and renal cell carcinoma: As recent literature postulated SH3BGRL2, a homolog of SH3BGR, to affect the Hippo signaling pathway in renal cell carcinoma, we aimed to find whether SH3BGR affects Hippo signaling in neonatal cardiomyocytes [31].